Skip to main content
Pulmonologist video

Dr Richard Russell and Dr Omar Usmani discuss the results of studies in which LAMA/LABA treatment was given early in the course of COPD.

3:12
Pulmonologist video

Dr Richard Russell and Dr Omar Usmani discuss the latest data relating to ICS use, including the successful withdrawal of ICS.

7:43
Pulmonologist video

Dr Omar Usmani, an expert in inhaler devices, describes the importance of these for effective treatment of COPD.

5:22
Pulmonologist video

Drs Russell and Usmani discuss various aspects comprising effective non-pharmacological management of COPD.

4:35
Pulmonologist video

Dr Richard Russell and Dr Omar Usmani discuss the use and effect of e-cigarettes in patients with COPD.

3:18
Pulmonologist video

Dr Richard Russell and Dr Omar Usmani discuss data from the 2015 ATS and ERS conferences on the comorbidities in patients with COPD.

4:24
Pulmonologist video

Drs Russell and Usmani discuss data from the 2015 ATS and ERS conferences, about safety data and CV risk associated with pharmacological management of COPD

2:19
Pulmonologist video

Following the 2015 ATS and ERS conferences, Drs Richard Russell and Omar Usmani discuss the challenges that primary care doctors face in recognising COPD.

3:46
Pulmonologist video

Drs Richard Russell and Omar Usmani discuss the value of screening for patients at risk of COPD, and the impact of biomass fuels on COPD prevalence.

3:42

Disclaimer

Using this link will let you leave a website of Boehringer Ingelheim International GmbH (“BI”) or to a different domain under the control of BI. In the event that the linked site is not under the control of BI but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, BI shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites. This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by BI of the site.

Continue

Welcome to RespiratoryXchange for international healthcare professionals outside the United States of America.

This website is an international information resource intended for international healthcare professionals outside the United States of America (US) who are interested in medical information on respiratory diseases such as COPD.

While the Internet serves a global community, the pharmaceutical industry is subject to country-specific regulatory considerations. This means that the registration status and approved product labels of the mentioned medicinal products may not be the same in different countries. Please refer to your local prescribing information for full details on the respective medicinal products.

By clicking on the link below you are declaring and confirming that you are a healthcare professional outside the United States of America and have read and understood this disclaimer.

I accept Leave website Go to website for healthcare professionals in the US